Read the original post: PLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business Update
Read the original post: PLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business Update
Read the original: Imugene’s onCARlytics combination with Celularity’s placental-derived off-the-shelf allogeneic CYCART-19 T cells preclinical data presented at...
View original post here: Theriva Biologics Reports Third Quarter 2022 Operational Highlights and Financial Results
See the original post here: Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
Originally posted here: CRISPR Therapeutics Presents Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
See original here: vTv Therapeutics Announces 2022 Third Quarter Financial Results and Provides Corporate Update
Read more: Eloxx Pharmaceuticals Reports Third Quarter 2022 Financial and Operating Results and Provides Business Update
Read more: Predicine to Introduce PredicineCOMPLETE™, its Genome-Wide Liquid Biopsy Solution, at the Society for Immunotherapy of Cancer (SITC) 37th Annual...
Originally posted here: IBEX Reports Results for the Year Ended July 31, 2022
Follow this link: HilleVax to Participate in November Investor Conferences
Recent Comments